Integration of genetic counsellors in genomic testing triage: Outcomes of a genomic consultation service in British Columbia, Canada.
Adolescent
Adult
British Columbia
Child
Child, Preschool
Facilities and Services Utilization
/ statistics & numerical data
Female
Genetic Counseling
/ organization & administration
Genetic Testing
/ statistics & numerical data
Health Plan Implementation
/ statistics & numerical data
Humans
Infant
Male
Referral and Consultation
/ organization & administration
Triage
/ organization & administration
Whole Genome Sequencing
/ statistics & numerical data
Genetic counsellors
Genome-wide sequencing
Genomic testing recommendations
Health services implementation
Triage
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
04
06
2020
revised:
14
07
2020
accepted:
20
07
2020
pubmed:
18
8
2020
medline:
11
8
2021
entrez:
18
8
2020
Statut:
ppublish
Résumé
Clinical diagnostic genome-wide (exome or genome) sequencing (GWS) in British Columbia requires funding approval by a provincial agency on a case-by-case basis. The CAUSES Clinic was a pediatric translational trio-based GWS study at BC Children's and Women's Hospitals. Referrals to the CAUSES Clinic were made through a Genomic Consultation Service (GCS), a multidisciplinary team led by genetic counsellors that provided advice regarding genomic testing for physicians considering GWS for their patients. Here we review the outcomes of the GCS, focusing on patients not recommended for the CAUSES Study. Demographic, clinical, and testing data were abstracted from patient charts. Logistic regression analysis was used to explore associations between demographic and clinical variables and two outcomes: the type of recommendation and referring physicians' decisions to follow the recommendation. Of 972 GCS referrals, 248 patients were not referred to the CAUSES Study. GWS (vs. a targeted test; e.g. multi-gene panel) was more likely to be recommended to physicians of patients with ID than physicians of patients without ID (OR = 2.98; 95% CI = 1.46 to 6.27; n = 149). In total, 40% of physicians who were recommended to pursue clinical genomic testing submitted an application for funding approval; 71% of applications were approved for funding. Among approved tests, 50% resulted in a diagnosis, including 33% of targeted tests and 82% of GWS tests (χ The GCS provided an effective model in which physicians can interface with genetic specialists, including genetic counsellors, to facilitate appropriate genomic test selection.
Identifiants
pubmed: 32798762
pii: S1769-7212(20)30518-8
doi: 10.1016/j.ejmg.2020.104024
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104024Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.